Results 141 to 150 of about 42,767 (197)

Effectiveness of Riboflavin in Inherited Metabolic Diseases: A Systematic Review

Journal of Inherited Metabolic Disease, Volume 49, Issue 3, May 2026.
ABSTRACT Riboflavin (RF, vitamin B2) is an essential vitamin of which the co‐factors are critical to numerous cellular processes. RF is used as a treatment for inherited metabolic diseases (IMDs), although its effectiveness in many disorders has not been established.
Bregje Jaeger, Nina N. Stolwijk, Femke Aaldering, Charlotte A. Ruys, Marije Smits, Nicole I. Wolf, Carla E. M. Hollak, Annet M. Bosch   +7 more
wiley   +1 more source

Pterostilbene attenuates heart failure by inhibiting myocardial ferroptosis through SIRT1/GSK-3β/GPX4 signaling pathway. [PDF]

Heliyon
Zhang F, Zeng Z, Zhang J, Li X, Yang W, Wei Y, Guo X.   +6 more
europepmc   +1 more source

Gene therapy for lysosomal storage diseases: Current clinical trial prospects. [PDF]

Front Genet, 2023
Kido J, Sugawara K, Nakamura K.
europepmc   +1 more source

Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study [PDF]

, 2016
et al,, Pestronk, Alan
core   +1 more source

Carrier screening in the reproductive setting—Are there medical implications for the heterozygote?—A guide for clinicians

Pregnancy, Volume 2, Issue 3, May 2026.
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld, Nicole Kasatkin, Bi Liu Yu, Milen Velinov, Justin S. Brandt, Elena Ashkinadze   +5 more
wiley   +1 more source

SuoquanYishen formula improves renal cellular senescence by inhibiting YTHDF1-Rubicon axis to promote autophagy in diabetic kidney disease. [PDF]

Front Pharmacol
Yan Z, Zhang L, Ma T, Yuan Y, Kang Y, Liu S, Chen B, Li K, Xiao M, Xie Y.   +9 more
europepmc   +1 more source

Portal-systemic shunting for metabolic disease [PDF]

, 1985
Iwatsuki, S, Porter, KA, Starzl, TE
core  

Thiol post‐translational modifications modulate allosteric regulation of the OpcA–G6PDH complex through conformational gate control

Protein Science, Volume 35, Issue 5, May 2026.
Abstract In cyanobacteria, the redox‐sensitive protein OpcA acts as a metabolic switch for G6PDH, enabling rapid adjustment of reducing power generation from glycogen catabolism and thereby precisely regulating carbon flux between anabolic and catabolic pathways.
Hoshin Kim, Song Feng, Pavlo Bohutskyi, Xiaolu Li, Daniel Mejia‐Rodriguez, Tong Zhang, Wei‐Jun Qian, Margaret S. Cheung   +7 more
wiley   +1 more source

Polysaccharide storage myopathy - the story so far [PDF]

, 2015
Annandale, Annandale, Arad, Baird, Borgia, Borgia, Byrne, De La Corte, De La Corte, De La Corte, DiMauro, Firshman, Firshman, Firshman, Herszberg, Hunt, Johlig, Lacombe, Larcher, Ledwith, Lentz, McCoy, McCue, McCue, McCue, McCue, McCue, McCue, Naylor, Naylor, Quiroz-Rothe, Ribeiro, Schwarz, Sierra, Soliman, Stanley, Stanley, Valberg, Valberg, Valberg, Valberg, Valberg, Valentine, Valentine, Valentine, Valentine   +45 more
core   +2 more sources

A Review of Metal–Organic Framework (MOF) Based Active Food Packaging: Materials Selection, Cellulose Matrices Current Advances, Synthesis and Characterizations

Packaging Technology and Science, Volume 39, Issue 5, Page 533-572, May 2026.
Active packaging offers an effective approach to extending food shelf life. This review summarizes the past decade of progress in metal‐organic framework (MOF)‐based active food packaging, highlighting material selection, characterization, challenges, and future prospects.
Belladini Lovely, Young‐Teck Kim, Haibo Huang, Novitri Hastuti, Su Jung Hong   +4 more
wiley   +1 more source